High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer-Reference-Cited by-同舟云学术

High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer

Published:2019-12-10 Issue:2 Volume:43 Page:237-247
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Zaanan Aziz,Calmel Claire,Henriques Julie,Svrcek Magali,Blons Hélène,Desbois-Mouthon Christèle,Merabtene Fatiha,Goumard Claire,Parc Yann,Gayet Brice,Taieb Julien,Validire Pierre,Louvet Christophe,Fléjou Jean-François,Le Bouc Yves,Praz Françoise^ORCID

Funder

Institut National Du Cancer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13402-019-00484-6.pdf

Reference43 articles.

1. L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent, A. Jemal, Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108 (2015)

2. R. Labianca, B. Nordlinger, G.D. Beretta, S. Mosconi, M. Mandala, A. Cervantes, D. Arnold and E.G.W. Group, Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24 Suppl 6, vi64–72 (2013)

3. T. Andre, C. Boni, M. Navarro, J. Tabernero, T. Hickish, C. Topham, A. Bonetti, P. Clingan, J. Bridgewater, F. Rivera, A. de Gramont, Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27, 3109–3116 (2009)

4. J.P. Kuebler, H.S. Wieand, M.J. O'Connell, R.E. Smith, L.H. Colangelo, G. Yothers, N.J. Petrelli, M.P. Findlay, T.E. Seay, J.N. Atkins, J.L. Zapas, J.W. Goodwin, L. Fehrenbacher, R.K. Ramanathan, B.A. Conley, P.J. Flynn, G. Soori, L.K. Colman, E.A. Levine, K.S. Lanier, N. Wolmark, Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07. J Clin Oncol 25, 2198–2204 (2007)

5. S.R. Alberts, D.J. Sargent, S. Nair, M.R. Mahoney, M. Mooney, S.N. Thibodeau, T.C. Smyrk, F.A. Sinicrope, E. Chan, S. Gill, M.S. Kahlenberg, A.F. Shields, J.T. Quesenberry, T.A. Webb, G.H. Farr Jr., B.A. Pockaj, A. Grothey, R.M. Goldberg, Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: A randomized trial. JAMA 307, 1383–1393 (2012)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circular RNA circ_0006089 regulates the IGF1R expression by targeting miR-143-3p to promote gastric cancer proliferation, migration and invasion;Cell Cycle;2022-05-11

2. miR‑4458 directly targets IGF1R to inhibit cell proliferation and promote apoptosis in hemangioma;Experimental and Therapeutic Medicine;2020-02-25